Prevalence of hepatopancreatic injury and clinical outcomes in patients with COVID-19 in USA.

Vaibhav RastogiRanjit BanwaitDevina SinghHale TokluLexie FinerDipendra ParajuliLatha Ganti

Published in: International journal of emergency medicine (2021)

COVID-19 can cause liver injury. Mortality, disease severity, and hospital length of stay are increased in COVID-19 patients with hepatopancreatic injury.

Keyphrases

liver injury
coronavirus disease
drug induced
sars cov
risk factors
healthcare
respiratory syndrome coronavirus
cardiovascular events
adverse drug
type diabetes